| | |
VEGF expression
| | |
MVD expression
| |
|---|
| |
β
|
HR (95% CI)
|
P
|
β
|
HR (95% CI)
|
P
|
|---|
|
COX-2 expression
| | | | | | |
|
High
|
2.286
|
9.836 (3.387 - 28.564)
|
0.000
|
1.146
|
3.147 (1.152 - 8.598)
|
0.025
|
|
Low
|
1.000
| | |
1.000
| | |
|
TNM stage
| | | | | | |
|
III + IV
|
0.061
|
1.063 (0.493 - 2.289)
|
0.877
|
0.025
|
1.025 (0.493 - 2.132)
|
0.947
|
|
I + II
|
1.000
| | |
1.000
| | |
|
Histology
| | | | | | |
|
Adeno
|
-0.300
|
0.741 (0.303 - 1.810)
|
0.510
|
0.400
|
1.491 (0.649 - 3.425)
|
0.346
|
|
SCC
|
1.000
| | |
1.000
| | |
|
Differentiation
| | | | | | |
|
Poor
|
-0.292
|
0.746 (0.198 - 2.809)
|
0.665
|
-0.969
|
0.379 (0.106 - 1.359)
|
0.137
|
|
Well and moderate
|
1.000
| | |
1.000
| | |
|
Smoking
| | | | | | |
|
Yes
|
-0.775
|
0.461 (0.145 - 1.461)
|
0.188
|
-0.481
|
0.618 (0.214 - 1.785)
|
0.374
|
|
No
|
1.000
| | |
1.000
| | |
|
Sex
| | | | | | |
|
Male
|
-1.005
|
0.366 (0.101 - 1.330)
|
0.127
|
-0.511
|
0.600 (0.170 - 2.110)
|
0.426
|
|
Female
|
1.000
| | |
1.000
| | |
|
Age
| | | | | | |
|
≥ 60 yrs
|
0.316
|
1.371 (0.413 - 4.551)
|
0.606
|
-0.223
|
0.800 (0.251 - 2.551)
|
0.706
|
|
< 60 yrs
|
1.000
| | |
1.000
| | |
- Abbreviations: HR, hazard ratio; CI, confidence interval of the estimated HR; Adeno, adenocarcinoma; SCC, squamous cell carcinoma
